GeoPolitics Pulse

The Heartbeat of World events

Japan’s Taisho Pharma faces claim over buyout price from Curi RMB, Oasis – Nikkei Asia

by ·

TOKYO — Investment funds Curi RMB Capital and Oasis Management are contesting the pricing of Taisho Pharmaceutical Holdings’ management buyout in …Read More

Related posts:

  1. Blackstone eyes $10bn in Japan deals amid buyout fund influx – Nikkei Asia
  2. Seven & i’s proposed buyout to require preapproval by Japan – Nikkei Asia
  3. Japan’s 7-Eleven owner eyes going private with $38bn buyout – Nikkei Asia
  4. Eversana brings pharma commercialization services to Germany – Fierce Pharma
  5. Focus On: RMB hosts inaugural West African Think Summit – YouTube